A randomized study comparing the effect of platelet-rich plasma and platelet-poor plasma for the treatment of plantar fasciitis
DOI:
https://doi.org/10.33448/rsd-v12i9.43168Keywords:
Plantar Fasciitis; Pain; Platelet-rich plasma.Abstract
Objective: To verify the effectiveness of therapy with platelet-rich plasma (PRP) in patients with plantar fasciitis, this prospective, longitudinal, double-blind study was carried out. Methodology: Twenty-three participants with chronic plantar fasciitis aged > 20 years, already treated with conventional methods were included. Participants were randomly divided into platelet-poor plasma (PPP) and platelet-rich plasma (PRP) groups. Double centrifugation was carried out to prepare the platelets samples and two millilitres of PPP (supernatant fraction) or PRP (sediment fraction) were mixed with 1mL of 2% calcium gluconate solution and injected in the plantar fascia, as a single dose. A follow-up at 15 days and then every 60 days up to 180 days of application was carried out and a visual analogue scale (VAS) for pain assessment and the quality-of-life scale validated by the American Orthopedic Foot and Ankle Society (AOFAS) were used to measure the outcomes. Results: A reduction in pain (VAS 8 to 4), in both groups, was seen in the first 15 days and remained up to the 6th month after the application of plasmas, however, no difference was observed between the groups. No significant improvement was observed in the quality of life of the patients. Conclusion: PPP or PRP were able to reduce the VAS, but the presence of platelets did not have a role in the pain relief. Other factors in the plasma may play a role in reducing the pain caused by plantar fasciitis for a period of up to 180 days.
References
Amin I. & Gellhorn A. C. (2019). Platelet-rich plasma use in musculoskeletal disorders: are the factors important in standardization well understood? Physical Medicine And Rehabilitation Clinics Of North America. 30(2):439-449. DOI: 10.1016/J.PMR.2018.12.005
Andia I, Sanchez M & Maffulli N. (2010) Tendon healing and platelet-rich plasma therapies. Expert opinion on biological therapy. 10(10):1415-26. doi: 10.1517/14712598.2010.514603.
Chahla J., Cinque M. E., Piuzzi N. S., Mannava S., Geeslin A. G., Murray I. R., Dornan G .J., Muschler G. F. & LaPrade R. F. (2017). A Call for Standardization in Platelet-Rich Plasma Preparation Protocols and Composition Reporting: A Systematic Review of the Clinical Orthopaedic Literature. Journal of Bone and Joint Surgery. 99(20):1769-1779. doi: 10.2106/JBJS.16.01374
Cardenuto Ferreira R (2014). Talalgia: plantar fasciitis. Revista Brasileira de Ortopedia. 49(3):213-7. doi: 10.1016/j.rboe.2014.03.012.
Costa P. A. & Santos P.(2016). Platelet rich plasma: a review of its therapeutic use. Revista Brasileira de Análises Clínicas.;48:311-9
Costa M. T., Backer R. C. & Ferreira R. C. (2014). Clinical and functional evaluation of forefoot reconstruction in patients with rheumatoid arthritis. Revista Brasileira de Ortopedia. 49(2):167-73. doi: 10.1016/j.rboe.2014.03.020
De Souza T. R. (2017). Eficácia do uso de palmilhas biomecânicas para a correção cinemática do padrão de pronação excessiva da articulação subtalar. Revista brasileira de fisioterapia.;9:275–82
Dohan D. M., Choukroun J., Diss A., Dohan S. L., Dohan A. J., Mouhyi J. & Gogly B. (2006). Platelet-rich fibrin (PRF): a second-generation platelet concentrate. Part II: platelet-related biologic features. Oral surgery,oral medicine, oral pathology, oral radiology, and endodontics.. 101(3):e45-50. doi: 10.1016/j.tripleo.2005.07.009
Dohan D. M. & Choukroun J. (2007). PRP. cPRP. PRF. PRG. PRGF. FC. How to find your way in the jungle of platelet concentrates? Oral surgery,oral medicine, oral pathology, oral radiology, and endodontics,103:305–6
Faul F., Erdfelder E., Lang A. G. & Buchner A. (2007). G*Power 3: a flexible statistical power analysis program for the social, behavioral, and biomedical sciences. Behavior research methods. 39(2): 175-91. doi: 10.3758/bf03193146
Fernandes T .L., Pedrinelli A. & Hernandez A. J. (2015). Muscle injury - Physiopathology diagnosis, treatment and clinical presentarion. Revista Brasileira de Ortopedia. 46(3):247-55. doi: 10.1016/S2255-4971(15)30190-7
Franceschi F., Papalia R., Franceschetti E., Paciotti M., Maffulli N. & Denaro V. (2014). Platelet-rich plasma injections for chronic plantar fasciopathy: a systematic review. British Medical Bulletin. 112(1):83-95. doi: 10.1093/bmb/ldu025
Freire M. R. M., da Silva P. M. C., Azevedo A. R., Silva D. S., da Silva R. B. B. & Cardoso J. C. (2020). Comparative Effect between Infiltration of Platelet-rich Plasma and the Use of Corticosteroids in the Treatment of Knee Osteoarthritis: A Prospective and Randomized Clinical Trial. Revista Brasileira de Ortopedia. (Sao Paulo). 55(5):551-556. doi:10.1016/j.rbo.2018.01.001
Hohmann E., Tetsworth K. & Glatt V. (2021). Platelet-Rich Plasma Versus Corticosteroids for the Treatment of Plantar Fasciitis: A Systematic Review and Meta-analysis. The American Journal of Sports Medicine. 49(5):1381-1393. doi: 10.1177/0363546520937293
Jarde O., Diebold P., Havet E., Boulu G. & Vernois J. (2003). Degenerative lesions of the plantar fascia: surgical treatment by fasciectomy and excision of the heel spur. A report on 38 cases. Acta orthopaedica Belgica. 69(3):267-74
Landesberg R., Roy M. & Glickman R. S. (2000). Quantification of growth factor levels using a simplified method of platelet-rich plasma gel preparation. Journal of Oral Maxillofacial Surgery. 58(3):297-300; discussion 300-1. doi: 10.1016/s0278-2391(00)90058-2
Lei H, Gui L & Xiao R. (2009). The effect of anticoagulants on the quality and biological efficacy of platelet-rich plasma. Clinical Biochemistry. 42(13-14):1452-60. doi: 10.1016/j.clinbiochem.2009.06.012
López-López, D., Pérez-Ríos, M., Ruano-Ravina, A., Losa-Iglesias, M. E., Becerro-de-Bengoa-Vallejo, R., Romero-Morales, C., Calvo-Lobo, C., & Navarro-Flores, E. (2021). Impact of quality of life related to foot problems: a case-control study. Scientific reports,11(1), 14515. https://doi.org/10.1038/s41598-021-93902-5
Lourenço, B. M., Campos, M. G. M., Maia, L., Castro, B., Trede, R. G., & Oliveira, V. C. (2023). Efficacy of pharmacological and non-pharmacological therapies on pain intensity and disability for plantar fasciitis: a systematic review and meta-analysis. British journal of sports medicine, bjsports-2022-106403. Advance online publication. https://doi.org/10.1136/bjsports-2022-106403
Macedo A. P. (2004). Plasma Rico Em Plaquetas : Uma Análise Quantitativa e Plasma Rico em Plaquetas : Uma Análise Quantitativa E. Repositorio.Ufsc.Br repositorio.Ufsc.Br.
Malahias M. A., Mavrogenis A .F., Nikolaou V. S., Megaloikonomos P. D., Kazas S. T., Chronopoulos E. & Babis G. C. (2019). Similar effect of ultrasound-guided platelet-rich plasma versus platelet-poor plasma injections for chronic plantar fasciitis. Foot (Edinb). 38:30-33. doi: 10.1016/j.foot.2018.11.003
Nusca A., Tuccinardi D., Pieralice S., Giannone S., Carpenito M., Monte L., Watanabe M., Cavallari I., Maddaloni E., Ussia G .P., Manfrini S. & Grigioni F. (2021). Platelet Effects of Anti-diabetic Therapies: New Perspectives in the Management of Patients with Diabetes and Cardiovascular Disease. Frontiers in pharmacology. 12:670155. doi: 10.3389/fphar.2021.670155
Perez A. G. M., Lana J. F. S. D., Rodrigues A. A., Luzo A. C .M., Belangero W. D. & Santana M. H. A. (2014). Relevant Aspects of Centrifugation Step in the Preparation of Platelet-Rich Plasma. ISRN Hematology. 25:176060. DOI:10.1155/2014/176060
Pochini A. C., Antonioli E., Bucci D. Z., Sardinha L. R., Andreoli C. V., Ferretti M., Ejnisman B., Goldberg A. C. & Cohen M. (2016). Analysis of cytokine profile and growth factors in platelet-rich plasma obtained by open systems and commercial columns. Einstein (Sao Paulo). 14(3):391-397. doi: 10.1590/S1679-45082016AO3548
Rabadi, D., Seo, S., Wong, B., Chung, D., Rai, V., & Agrawal, D. K. (2022). Immunopathogenesis, early Detection, current therapies and prevention of plantar Fasciitis: A concise review. International immunopharmacology, 110, 109023. https://doi.org/10.1016/j.intimp.2022.109023
Rodrigues, R. C., Masiero, D., Mizusaki, J. M., Imoto, A. M., Peccin, M. S., Cohen, M., & Alloza, J. F. M.. (2008). Tradução, adaptação cultural e validação do "American Orthopaedic Foot and Ankle Society (AOFAS) Ankle-Hindfoot Scale". Acta Ortopédica Brasileira, 16(2), 107–111. https://doi.org/10.1590/S1413-78522008000200009
Sathyendra, K. G., Dnyandeo Solankey, R., Singh, M., Venkatesh Kumar, S., Singh, G., & Gupta, M. M. (2023). Comparative study of local injections of autologous platelet rich plasma versus corticosteroid in management of chronic plantar fasciitis. Journal of clinical orthopaedics and trauma,43, 102225. https://doi.org/10.1016/j.jcot.2023.102225
Sepúlveda C., Palomo I. & Fuentes E. (2017). Antiplatelet activity of drugs used in hypertension, dyslipidemia and diabetes: Additional benefit in cardiovascular diseases prevention. Vascular Pharmacology. 91:10-17. doi: 10.1016/j.vph.2017.03.004
Silva, R. D. O.; Sousa, G.A.; Rebêlo, V.C.N. (2022). Dry neeling method and its effectiveness in the treatment of Plantar fascitis: review of the literature of randomized clinical trials. Research, Society and Development. [S. l.], v.11, n.5, p. e31311528416. DOI: 10.33448/rsd-v11i5.28416.
Teixeira M. V. T. Takamori E. R. Menezes K. Carias R. B. V. & Borojevic R. (2018). Utilização de plaquetas e de produtos derivados de plaquetas humanas em terapias avançadas. Vigilância Sanitária em Debate;28;6:125
The Jamovi Project (2021). Jamovi (Version 1.6) [Computer Software]. Retrieved from https://www.jamovi.org
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2023 Elcio Valotto-Junior; Sandra Bin Silva; Luis Henrique Garcia Muniz; Fernanda Ferreira Evangelista; Luciano Henrique Gazoni Scremin; Elisabete Mitiko Kobayashi; Elza Kimura
This work is licensed under a Creative Commons Attribution 4.0 International License.
Authors who publish with this journal agree to the following terms:
1) Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution License that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal.
2) Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.
3) Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work.
